The Academy of Oncology Nurse Navigators white paper, "Assessing the Creative Application and Usefulness of NSider: A Tactical Tool for the Oncology Nurse Navigator" was published in the journal, The Oncology Nurse-APN/NP.

Scientists find more genes tied to alcoholism riskHealthDay News via Medical XpressNew research pinpoints 11 gene variations that appear to be linked to a higher risk of alcoholism. However, their impact seems to be small in individuals, and the findings may be too limited to be immediately useful in terms of prevention or treatment, an expert said. Still, the results could provide more insight into the mysterious role that genes play in determining why some people drink and don't get addicted while others become alcoholics, the researchers said.

Genetic match? Why people tend to marry those with similar DNALiveScience via CBS NewsGoing on a first date? The chance that it leads to wedding bells may depend, in part, on how similar his or her DNA is to yours.
New research finds that people tend to pick spouses whose genetic profile shares similarities with their own. The effect is subtle (other similarities, such as similarity in education, have a larger influence), but it's important to understand that mating isn't truly genetically random, researchers report in the journal Proceedings of the National Academy of Sciences.

Patient data-driven personalization key to fixing today's broken health assessmentsWiredOn average, we live eight years longer than we did in 1970. The problem is, even though we're living longer than we ever have before, we are not necessarily living healthier. In fact, we are living sicker in the last 10-15 years of life. Modern medicine and medical treatments are prolonging our lives, even helping us live with diseases that were otherwise fatal.

Is next generation sequencing ready for personalized medicine?LexologyNext generation sequencing promises to transform the delivery of healthcare by providing in one test diagnostic and prognostic information that had previously only been available in multiple analyses. One application of the information obtained from NGS is as a companion diagnostic for a therapeutic. A significant reduction in the overall cost to sequence the complete genome, most notably Illumina's announcement of the "$1,000 genome," makes NGS an attractive alternative to current locus-by-locus genetic analysis, and raises the prospect of near-term adoption of NGS in clinical medicine.

Stem cell therapy shows promise for multiple sclerosisFox NewsFor patients with multiple sclerosis, current treatment options only address early-stage symptoms of the debilitating disease. Now, new research has found a potential treatment that could both stop disease progression and repair existing damage.
In a study published in Stem Cell Reports, researchers utilized a group of paralyzed mice genetically engineered to have an MS-like condition.

Proof that cancer stem cells exist? Medical News TodayThere has been much controversy over the compelling idea of cancer stem cells — a small subset of "master cells" that drives the growth and development of a patient's cancer. Now an international team of scientists that tracked the gene mutations driving cancer in patients with a rare blood condition that frequently develops into acute myeloid leukemia, says it has proved conclusively that cancer stem cells exist.

Why so much fake, unduplicable stem cell research?Medscape What is going on in the field of regenerative medicine with respect to stem cell research? We have recently had yet another in a long series of scandals involving claims about the ability to manipulate stem cells in ways that turned out to be utterly untrue and fraudulent. In this case, a scientist in Japan said that she was able to make adult stem cells revert to embryo-like stem cells with some pretty simple chemical exposures. It was announced in leading journals and covered extensively by the media. Then she had to admit that no one could duplicate what she had done and confessed that she had made it up.

Wireless medical implant is smaller than a grain of riceNBC NewsA breakthrough in wireless power has enabled the creation of a tiny medical implant, no larger than a grain of rice, that could be used as a pacemaker or in place of drugs. The Stanford Engineering team behind the new tech was led by Assistant Professor Ada Poon, and the great advance isn't actually the size of the electronic device — it's the way that device is powered.

Integrating telemedicine and mHealth into the health systemBy Jessica Taylor Many people think futuristic possibilities when they hear about telemedicine and mobile health, but the reality is that both will increase productivity and efficiency throughout the health system in the coming years. At the ATA 2014 Annual Meeting and Trade Show, healthcare colleagues were discussing how the alternative to face-to-face communication — telemedicine — has grown remarkably in the past few years and is continuing to do so.

FDA clears medical apps from InTouch Health, Gauss Surgical, othersmobihealthnewsBack at the beginning of May, we reported on several mobile health FDA clearances from the previous month. But the FDA has been even busier than that, clearing at least three other big name mobile products in April, and a few more already in May. First off, this month a couple of different iPad apps received FDA clearance.

Behind the white coats: Looking at the lifestyles of today's physiciansBy Dorothy L. Tengler When we visit our physicians, we usually don't think about the commitment they made to be able to treat us — four years of medical school, three to seven years of residency, another few years of fellowship. Most likely, physicians have spent seven to 10 years of their lives preparing to practice medicine. But that across-the-board time commitment doesn't make all physicians the same. In fact, a national survey of 125,000 practicing physicians revealed intriguing differences from finances and career plans to personal lifestyles.

Seasonal allergy treatments Grastek, Ragwitek approved by FDANewsdayAs allergy season rages on, two new oral allergy medications were approved this April by the FDA. Grastek and Ragwitek, much like Oralair, offer allergy patients a new alternative to the traditional allergy shot treatments. Less invasive than injections beneath the skin, these medications (taken under the tongue) are a new leg of what's called "immunotherapy," which works by building up an immunity to your trigger allergens.

This edition of the Genomics Biotech and Emerging Medical Technologies Institute eBrief was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!